We leverage the latest research completed by the nationally recognized University of Miami Miller School of Medicine to offer the latest treatments including promising new approaches through clinical trials. Our endocrinologists work closely with surgeons, fertility specialists, oncologists, nuclear medicine specialists, ophthalmologists, dietitians, and other health care professionals to provide complete care.

Thyroid associated ophthalmopathy (TAO) also known as Graves’ orbitopathy or thyroid eye disease is an autoimmune condition that can lead to changes in the appearance of the eye and eyelids, ocular discomfort, double vision, dry eyes and tearing, corneal exposure, and even blindness in some cases. This condition usually occurs in people with hyperthyroidism (overactive thyroid) or a history of hyperthyroidism due to Graves’ disease, but may also occur in patients with hypothyroidism or no known thyroid abnormalities.

Our oculoplastic surgeons evaluate patients with TAO, and have a variety of medical and surgical treatments to address both functional (loss of vision, double vision, extreme eye dryness) and cosmetic aspects of this disease. In addition, our surgeons are conducting ongoing research of TAO aimed at improving treatment for patients.